Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matejka Rebolj

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2009
Process performance of cervical screening programmes in EuropeGuglielmo Ronco, Marjolein van Ballegooijen, Nikolaus Becker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2025
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSISMatejka Rebolj, Adam R Brentnall, Julia Geppert, et al.
International Journal of Cancer|March 8, 2005
Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelinesAagje G Bais, Matejka Rebolj, Peter J F Snijders, et al.
British Journal of Cancer|July 8, 2025
HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devicesChristopher S Mathews, Alexandra Sargent, Kate Cuschieri, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2022
Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptionsEmily A Burger, Inge M C M de Kok, James F O'Mahony, et al.
Elife|October 12, 2022
A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptionsEmily A Burger, Inge M C M de Kok, James F O'Mahony, et al.
BMJ (Clinical Research Ed.)|February 8, 2019
Primary cervical screening with high risk human papillomavirus testing: observational studyMatejka Rebolj, Janet Rimmer, Karin Denton, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2009
Process performance of cervical screening programmes in EuropeGuglielmo Ronco, Marjolein van Ballegooijen, Nikolaus Becker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2025
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSISMatejka Rebolj, Adam R Brentnall, Julia Geppert, et al.
International Journal of Cancer|March 8, 2005
Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelinesAagje G Bais, Matejka Rebolj, Peter J F Snijders, et al.
British Journal of Cancer|July 8, 2025
HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devicesChristopher S Mathews, Alexandra Sargent, Kate Cuschieri, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2022
Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptionsEmily A Burger, Inge M C M de Kok, James F O'Mahony, et al.
Elife|October 12, 2022
A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptionsEmily A Burger, Inge M C M de Kok, James F O'Mahony, et al.
BMJ (Clinical Research Ed.)|February 8, 2019
Primary cervical screening with high risk human papillomavirus testing: observational studyMatejka Rebolj, Janet Rimmer, Karin Denton, et al.
Pageof 9